Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

GlycoMimetics long term debt from 1970 to 1969. Long term debt can be defined as the sum of all long term debt fields.

GlycoMimetics Long Term Debt 1970-1969 | GLYC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

GlycoMimetics long term debt from 1970 to 1969. Long term debt can be defined as the sum of all long term debt fields.

Related Stocks
Company Name	Market Cap
Chugai Pharmaceutical (CHGCY)	$95B
Zoetis (ZTS)	$66.3B
Takeda Pharmaceutical (TAK)	$46.8B
Daiichi Sankyo, - (DSNKY)	$41.7B
Summit Therapeutics (SMMT)	$18.2B
Sandoz Group AG (SDZNY)	$17.7B
Merck (MKKGY)	$17.2B
Astellas Pharma (ALPMY)	$16.9B
Shionogi (SGIOY)	$14.1B
United Therapeutics (UTHR)	$12.8B
Neurocrine Biosciences (NBIX)	$10B
IPSEN (IPSEY)	$8.6B
Orion OYJ (ORINY)	$8B
Madrigal Pharmaceuticals (MDGL)	$6.7B
Stevanato Group S.p.A (STVN)	$6.6B
Corcept Therapeutics (CORT)	$6.6B
Hikma Pharmaceuticals Plc (HKMPF)	$5.8B
Ono Pharmaceutical (OPHLF)	$5.5B
Grifols, S.A (GRFS)	$4.9B
Ionis Pharmaceuticals (IONS)	$4.5B
Soleno Therapeutics (SLNO)	$3.2B
Crinetics Pharmaceuticals (CRNX)	$2.8B
Catalyst Pharmaceuticals (CPRX)	$2.7B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.3B
Recursion Pharmaceuticals (RXRX)	$2.2B
Hypermarcas (HYPMY)	$2.1B
NewAmsterdam Pharma (NAMS)	$1.8B
Centessa Pharmaceuticals (CNTA)	$1.6B
BioCryst Pharmaceuticals (BCRX)	$1.5B
Guardian Pharmacy Services (GRDN)	$1.5B